Loading company…
Shanghai biotechnology company developing interventional treatment devices, including a fully degradable sinus drug stent system registered in 2017.
Based in Shanghai, China and established in 2012, Puyi Biotechnology researches, develops, produces and sells interventional treatment devices. Its sinus drug stent system obtained a product registration certificate in 2017 and it is fully degradable. Other products include nasal septum stents, eustachian tube balloons, olfactory reagents, cervical balloons, biodegradable ureteral stents and hyaluronic acid products for gynecology, urology and cosmetic medicine. The company planned to list on the Hong Kong Stock Exchange in 2021 and is at Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in